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Abstract: Primordial germ cells (PGCs) provide an excellent tool to better understand ancestor–descendent relationships as well as the
efficiency and molecular mechanisms governing pluripotency in the reprogramming of somatic cells, since the latter type of cells have
a relatively lower efficiency of conversion to pluripotent cells. This kind of comparison has gained credence from the commonalities
regarding the expression of key transcription factors such as octamer-binding transcriptionhttp://en.wikipedia.org/wiki/Transcription_
factor factor-4 (Oct3/4), SRY-related HMG box (Sox2), myelocytomatosis (c-Myc), and Nanog, as well as redundancy in terms of
Kruppel-like factor 2 (Klf2), Kruppel-like factor 5 (Klf5), estrogen-related receptor beta (Esrrb), and estrogen-related receptor gamma
(Esrrg) compensating for the absence of Kruppel-like factor 4 (Klf4). However, the exogenous addition of any one of these factors
was found to be important, thereby implying that the expression level is important. L-Myelocytomatosis (L-myc) was shown to
improve reprogramming efficiency without affecting tumorigenic potential. Molecular aspects of epigenetic reprogramming during
the acquisition of pluripotency, as well as tumorigenic potential, have also been discussed, thus providing an understanding of the
factors that can improve the former without increasing the possibility of neoplastic transformation. An improved understanding of the
molecular events would pave the way for the development and use of endogenous biomolecules as well as currently available chemical
reprogrammers for improving the efficiency of conversion of PGCs into cells of the stem cell lineage. Such chemicals, when adequately
tested, can possibly be an alternative to viral vectors, since the introduced transgenes can become oncogenic.
Key words: Primordial germ cells, stem cells, chemical/genetic reprogramming, pluripotency, transcription factors, epigenetic, induced
pluripotent stem cells, embryonic germ cells, embryonic stem cells, epiblast stem cells

1. Introduction
Takahashi and Yamanaka short-listed 4 transcription
factors (TFs), called “Yamanaka factors” (Oct3/4, Sox2, Klf4, and c-Myc), to genetically reprogram mouse
fibroblasts to acquire pluripotency (viral transduction).
This implied that the 4 factors were involved in the
induction of genes that would normally have been
expressed in the embryonic state. This Nobel Prizewinning work is of immense significance, since the use
of autologous somatic cells can resolve immunological
rejection-based concerns. Furthermore, they can possibly
be used as cell-based disease models (Takahashi and
Yamanaka, 2006) and targeted redifferentiation can be done
to produce autologous cells of the desired cell type (Ieda
et al., 2010). However, the low efficiency of conversion, as
well as the lack of a precise understanding of the molecular
mechanisms governing pluripotency in somatic cells, has
prompted work on other cell-based model systems (Hanna
et al., 2010) like primordial germ cells (PGCs). Evidence
for such approaches is discussed below. This review
* Correspondence: p.k.suresh@vit.ac.in

discusses the origin of PGCs (a unipotent cell type in mice
and humans), this cell type’s underlying pluripotent state,
and the concomitant epigenetic changes. Furthermore,
this review also elaborates upon chemical reprogramming
strategies since they are potentially a better option in
comparison with virally/episomally mediated introduction
of the important canonical transcription factors.
Near the juxtaposed extraembryonic ectoderm in mice,
PGCs are found within the proximal margin of the epiblast
(6.5 days post coitum (d.p.c.)). One day later (7.5 d.p.c.),
the alkaline phosphatase positive cells have migrated to
the mesodermal region (extraembryonic) near the base of
the allantois at the posterior end of the primitive streak.
By 10.5 d.p.c., the cells have reached the genital ridges,
their new and final destination after migrating through
the mesentery, subsequent to their association with the
hindgut endoderm and migration from the primitive
streak. Over a 5-day period (8.5–13.5 d.p.c.), the cells
proliferate about 167-fold. The cells in the female enter
the meiotic cell cycle, while there is growth arrest in
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males (Ginsburg et al., 1990). Molecular lineage tracing
experiments have provided strong evidence for the role of
the B-lymphocyte-induced maturation protein (Blimp-1,
also known as Prdm1, PRDI-BF1, and RIZ homology
domain) in providing an important signal to repress the
program in PGCs, followed by the adjacent somatic cells,
thereby playing an important role in the specification of
the 40 founder PGCs (Ohinata et al., 2005). Single-cell
microarray technology has shown that Blimp-1-dependent
pathways are involved in the repression of genes associated
with the somatic cell lineage in mice (Kurimoto et al.,
2008a). Apart from this molecular event in PGC germ-cell
specification, the reacquisition of potential pluripotency
and genomic reprogramming involves PRDM-14, another
PR-domain-containing key transcriptional regulator
(Kurimoto et al., 2008a, 2008b). Corroborative evidence for
the role of this protein was evident from studies on PRDM14 mutants in which the aforementioned 2 important
events did not occur even though Blimp-1 was present
(Yamaji et al., 2008). Earlier studies using a similar singlecell quantitative gene expression profiling approach have
shown that a proportion of cells express Hox-1b and Sox2. However, at a later stage, Hox-1b expression is repressed
and Sox-2 is reactivated (Yabuto et al., 2006), and Blimp-1
plays a critical role in this process (Kurimoto et al., 2008a).
A hierarchically ordered sequence of activation events is
also involved in the final stages of germ-cell specification.
These molecular events include the activation of Stella and
Nanos3 and the repression of Hox genes. Most importantly,
the coordinated induction of several specification genes
with high specificity requires the presence of Blimp-1 and
PRDM14 (Kurimoto et al., 2008a, 2008b).
Similar findings have been found linking human PGCs
to the establishment of pluripotency as well as epigenetic
reprogramming. This cell type from gonadal ridges and
mesenteries, 5–7 days after fertilization, was able to form
colonies of embryoid bodies resembling EG and pluripotent
stem cells. This experiment involved culturing these cells
on a feeder layer, in the presence of leukemia inhibitory
factor as well as basic fibroblast growth factor (bFGF/
FGF2) and forskolin, over a period of 7–21 days. These
alkaline phosphatase-positive cells expressed markers that
were indistinguishable from those found on embryonic
germ cells (EGCs) as well as pluripotent stem cells, such as
stage-specific embryonic antigen (SSEA-1, SSEA-3, SSEA4) and tumor rejection antigen (TRA-1–60 and TRA-1–
81). Last but not least, they were able to differentiate into
3 germ layers, which is one of the criteria for establishing
pluripotency (Shamblott et al., 1998). This finding has
been replicated by another research group in terms of the
production of clones of EGCs, derived from human PGCs
that resembled the EGCs produced by mouse PGCs (Li et
al., 2002). While there are similarities between EGCs and
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PGCs, there are distinct differences in the transcriptional
profiles, which may be cell line/strain-specific (Sharova
et al., 2007). Distinct markers, indicated in parentheses,
may help in segregating the unipotent PGCs (hemoglobin
alpha 1, doublesex and mab-3 related transcription factor
1, sperm protein associated with the nucleus, X-linked,
family member A1, and EH-domain containing 2 protein)
from multipotent EGCs such as unique expression
of importin 7, mediator complex subunit 7, RNA binding
motif protein 26, heat shock 60 kDa protein 1, and
Kirsten rat sarcoma viral oncogene homolog. There are
other genes exclusively expressed in embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs) related
to cellular metabolism, adhesion, and cell cycle whose
gene products may be a distinguishing feature for these
cell types in comparison with the EGCs, as well as help in
better defining the germ line pluripotent state (Pashai et
al., 2012). Furthermore, acquisition of the unipotent state
involves several parallel as well as sequential epigenetic
events (e.g., global demethylation) that are robust and
redundant (Hackett et al., 2012). Alternative cell types
(PGCs or ESCs from epiblast stem cells (EpiSCs)) can
be produced in vitro by altering the signaling cues.
Furthermore, differences have been reported between
EGCs and EpiSCs, with the former cell type resembling
ESCs more than the latter. These exciting findings provide
an impetus to use molecular profiling-based approaches
with PGCs to better understand transcriptional regulation
in terms of lineage commitment (Hayashi and Surani,
2009) in comparison with the data from ESC and EpiSCs.
Under defined/different experimental conditions,
endogenous expression of 3 out of the 4 key transcription
factors (Oct 3/4, Sox-2, and c-Myc) is important, but not
sufficient, for pluripotency. Furthermore, since these cells
do not express Klf4, its absence could be compensated for
by the expression of Klf2, Klf5, Esrrb, and Esrrg (Nagamatsu
et al., 2013). Corroborative evidence is available for the
role of L-Myc in establishing pluripotency and not tumor
formation. This implies that a distinct domain in L-myc
is involved in improving reprogramming efficiency
(Nakagawa et al., 2010). Hence, sufficient evidence has
been provided for the reader/scientist concerned to
illustrate the importance of isolating and studying PGCs
both in terms of lineage tracing and demonstrating links
with pluripotency factors, including molecular similarities
and differences in comparison with other cell types
like EGCs, ESCs, and EpiSCs. This type of molecular
information can be correlated with their epigenetic status
and may also help in providing details regarding factors
that can promote tumorigenicity. Furthermore, this calls
for an improved understanding of the molecular factors
regulating cell renewal versus differentiation, specifically
the role of bFGF-2 as well as LIF/STAT3, apart from
identifying back-up mechanisms in these processes.
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2. LIF, SCF, FGF2: self-renewal and differentiation
In the presence of FGF2, in vitro mouse PGCs have
increased capabilities of proliferating and forming
colonies of undifferentiated ESCs and can synergize
with Steel factor and LIF (Matsui et al., 1992). In in vitro
murine systems, it has been demonstrated that bFGF
is a powerful mitogen for PGCs (Donovan et al., 1994;
Resnick et al., 1998) and their presence can be correlated
with the expression of its cognate receptors (Resnick et al.,
1998). There is good evidence in the literature to indicate
that there are time- and concentration-dependent effects
mediated by FGF2 and the development of a subset with
endogenous FGF2 and FGF-receptor-3 in the nucleus
that precedes pluripotency (Durcova-Hills et al., 2006).
Trichostatin A, an inhibitor of histone deacetylase, can
substitute for FGF-2 in a cocktail containing LIF for the
dedifferentiation of PGCs into EGCs (Durcova-Hills et al.,
2008). This provided indirect evidence of the role of FGF-2
in this process, obviating the need to introduce exogenous
transgenes. Using a genetically modified Zebrafish model
system to prolong the life of mRNA of FGF-2 (gene
construct with the Nanos3 3’UTR), it was demonstrated
that FGF-2 significantly increased PGC numbers at 14 and
21 days after fertilization (Wong and Collidi, 2013).
Another study has documented that the combined
actions of SCF and/or LIF with forskolin, an activator of
adenylate cyclase, can activate PGC proliferation in vitro
(Dolci et al., 1993), as well as inhibit apoptosis (Pesce et
al., 1993), without the need for a feeder layer (Cheng et al.,
1994). Furthermore, bFGF, LIF, and SCF (Kit ligand) are
necessary and sufficient for PGC transformation into EGCs
(De Felici et al., 2009). A cocktail of factors containing
Kit ligand, LIF, bone morphogenetic factor, stromal cellderived factor, bFGF, and certain compounds (N-acetylL-cysteine, forskolin, retinoic acid) can promote the
survival and self-renewal of mouse PGCs in the absence of
support from somatic cells (Farini et al., 2005). In mouse
ESCs, Nanog has been associated with the undifferentiated
pluripotent state; heterozygous cells (Nanog +/-) could be
converted to multilineage descendants in the presence of
LIF. These descendants could be made undifferentiated
by the addition of Nanog (Hatano et al., 2005). There is
evidence in the literature to indicate that inactivation of
Akt signaling may be responsible for the differentiated
state (Watanabe et al., 2006). Fairly convincing evidence
using differentiation inhibitors (mitogen-activated
protein kinase (Erk1/2) cascade and glycogen synthase
kinase 3 inhibitor-2i cocktail) has supported the theory
that a combination of blockade of differentiation and a
concomitant upregulation of LIF-mediated self-renewal
mechanisms can produce EGCs without the need for FGF
or SCF (Leitch et al., 2010). In fact, the LIF/STAT3 pathway
has been implicated in the process of conversion of PGCs

from a unipotent to a pluripotent state (Leitch et al., 2013b).
Recent lineage tracing and cocktail standardization-based
experiments again point to the combinatorial effects of
bFGF as well as LIF and SCF in the formation of EGCs
(Nagamatsu and Suda, 2013), thereby providing an impetus
for studies involving other cell signaling pathways.
A recent paper has documented the biphasic nature
of Wnt signaling; the downstream TFs (Tcf1/Lef1 and
Tcf3/Tcf4) behave differently depending on the stage of
the reprogramming process (Ho et al., 2013). Earlier on,
activation of Wnt signaling can, via Tcf1/Lef1, upregulate
target genes that interfere with the early reprogramming. At
that stage of reprogramming, Tcf3/Tcf4 can activate, among
other genes, Tcf1/Lef1, which can act as transcriptional
repressors and thereby promote reprogramming. At a later
stage, Tcf3/Tcf4 can modulate the Tcf1/Lef1 responses and
convert them to transcriptional activators of targets that
interfere with reprogramming. In other words, at a later
stage, depletion of Tcf3/Tcf4 can enhance reprogramming.
Evidence is available for the involvement of Wnt3a
converting Tcf1/Lef1 into activators and preventing them
from becoming repressors (Ho et al., 2013).
3. Mechanisms of epigenetic reprogramming and
pluripotency
As indicated in the introduction, Blimp-1 (also known as
Prdm1), a known transcriptional repressor, is important
for the development of the mouse germ cell lineage;
its repression is a key early event in the differentiation
of pluripotent stem cells (Durcova-Hills et al., 2008),
even though it may not be absolutely mandatory for
reprogramming (Bao et al., 2012). However, Blimp-1,
Prdm14, and Tcfap2c play a combinatorial role in the
suppression of genes responsible for the somatic cell fate
and Prdm14 is necessary for the induction of epigenetic
reprogramming in mice (Yamaji et al., 2008; Grabole et
al., 2013). In this regard, the reported upregulation of
Blimp-1 in mouse PGCs is a dominant and independent
event in the repression of genes of the somatic lineage
for germ-cell specification. PRDM14 was also shown to
be involved in the reacquisition of potential pluripotency
and epigenetic reprogramming. (Kurimoto et al., 2008a,
2008b). In this regard, the use of the aforementioned 2i
cocktail (Ficz et al., 2013) by Nagamatsu et al. (2013) for
global hypomethylation is necessary to mimic epigenetic
reprogramming that may occur in vivo in PGCs. This
cocktail is known to downregulate the de novo methyl
transferases (DNMT3a and DNMT3b, and its regulator
DNMT3L). Further downregulation of hydroxylases Tet1
and Tet2 and the PRDM14-mediated downregulation
of DNMT3s induces the PGC-like pluripotent state
in epigenetic terms (Leitch et al., 2013a). Hence, the
inhibition of downstream differentiation processes,
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involving both MEK and GSK-3beta, may be involved.
The balance of hydroxyl-methylation and methylation
of certain cytosine residues also ties in pluripotency
(associated with the transient expression of the network
of pluripotency factors in these cells) with epigenetic
reprogramming (Seisenberger et al., 2012), while other
genomic imprints remain intact (Ficz et al., 2011; Hackett
et al., 2013). In this regard, Stella (one of the targets of
Blimp-1) is associated with the protection of the maternal
genome and the paternally imprinted genes from the
wave of global demethylation (Wossidlo et al., 2011).
This acquisition of pluripotency in mouse PGCs through
synergistic passive and active global demethylation
mechanisms, including deamination or oxidation of 5Mc
(Mansour et al., 2012), is also potentially coupled with base
excision repair and may be preceded by a demethylase
(Utx)-induced removal of the H3K27me3 histone mark
(histone modification) in PGCs and the transcriptional
activation of some pluripotency genes (Mansour et al.,
2012; Seisenberger et al., 2013). Methodologies that can be
used, with high resolution, to identify critical epigenetic
events that are involved in the transition from PGCs to
pluripotent stem cells (Kobayashi et al., 2013) would pave
the way for a better understanding of the complexities in
the epigenetic changes (Nagamatsu et al., 2012a, 2012b).
Such changes, including erasure and resetting of parental
imprints, as per the Waddington canalization of energydependent pathways, play an important role in restricting
development potency and decreasing capacity for germline
transmission through chimera formation (Li et al., 2009).
While studies have suggested that reprogramming is
inextricably linked to pluripotency, striking similarities
have been observed between reprogramming mechanisms
and neoplastic transformation. Replacement of c-Myc by
a Wnt pathway inhibitor and overexpression of 3 TFs can
improve reprogramming efficiency (Kidder, 2014). Loss
of the p53 tumor suppressor has been shown to increase
reprogramming efficiency in a manner analogous to the
cooperation between oncogenes in the conversion of
normal cells to tumorigenic ones. Transient inhibition of
the p53–p21 pathway, through the suppression of the Ink4/
ARF pathway locus, may also be important in overcoming
the barrier for reprogramming; this has also been reported
for human fibroblasts with ARF4a being important for
this cell type, unlike ARF for its murine counterpart
(Hemberger et al., 2009). In the case of PGCs, PGC
dedifferentiation is mediated by PI3K/Akt signaling via
the inhibition of p53, a downstream molecule of the PI3K/
Akt signal. Furthermore, these cells can be converted into
ESCs under appropriate culture conditions, indicating that
the 2 states are metastable. Further, these interconvertible
states may be regulated by common epigenetic factors,
warranting more studies with PGCs for an improved
understanding of the factors governing reprogramming
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during the production of its derivatives (Yamano et
al., 2010; Kimura and Nakano, 2011). Such approaches
provide a logical and sound scientific approach to using
the aforementioned key endogenous biomolecules as
templates for the development of chemicals (experimental
probes/chemical reprogrammers) (Masuda et al., 2013).
This approach can possibly obviate the need for the
virally mediated introduction of genes, which can become
oncogenic, even though integration-free vectors are
currently available (Yu et al., 2009; Okita et al., 2011).
4. Chemical reprogramming strategies
While there are a lot of published studies on chemical
reprogramming strategies, data specifically related to
chemical reprogramming in primordial germ cells are
limited. Kimura et al. (2015) have shown that, in the
absence of bFGF and SCF, LIF and a combination of
chemicals (TGFβR inhibitor and/or Kempaullonemimicking Sox-2 and Klf4, respectively) generated
pluripotent stem cells using conventional ESC culturing
procedures (Kimura et al., 2015). However, due to the
several commonalities in signaling mechanisms among
PGCs, EGCs, ESCs, and EpiSCs, data obtained from small
molecule compounds and reprogramming in cell types
other than PGCs can provide pointers for development
of similar approaches to study and improve the efficiency
of this process. Key studies published recently have been
briefly reviewed. A novel chemical (CYT296) was shown
to increase the efficiency of OSKM-mediated induction
of iPSCs from mouse embryonic fibroblasts (MEFs) and
this reprogramming was accompanied by chromatin
remodeling (formation of a decondensed euchromatinlike structure, which is considered to be necessary for
development into a pluripotent state) (Wei et al., 2014).
In another study, transient folate deprivation with a new
combination of small-molecule compounds (sodium
butyrate, A-83-01, CHIR99021, and Y-27632 in place of
Sox-2 and c-Myc) and Oct4 and Klf4 could reprogram
MEFs at an accelerated rate in MEFs. The resultant cell
lines resembled ESCs (Hu et al., 2014). Approaches such
as these can help in dissecting the epigenetic processes
acquired during reprogramming from the background
epigenetic marks present in the somatic tissue of origin of
these iPSCs (Vaskova et al., 2013).
Among the 4 major transcription factors, Oct4
has continued to be a challenge in terms of finding a
chemical replacement. BIX-02194 (G9a methyltransferase
inhibitor) has been shown to shift the epigenetic balance
towards activation of endogenous Oct4 in reprogramming
of mouse fetal neural progenitor cells. However, this
approach required the viral transduction of the remaining
3 transcription factors (Shi et al., 2008). Subsequent
work involved the systematic development of successive
chemical screens. The first step involved development of
molecules that would replace Sox-2, Klf4, and c-Myc. The
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molecules were valproic acid (HDAC inhibitor), GSK3-β
inhibitor CHIR99021, TGF-β inhibitor E-616542, and
monoamine oxidase inhibitor tranylcypromine (VC6T)
(Li et al., 2011). The second step involved chemicals that
would replace Oct4; c-AMP agonist forskolin was identified
for this purpose. In order to complete the reprogramming,
other components identified were 3-deazaneplanocin A,
an S-adenosylhomocysteine hydrolase inhibitor, as well as
the 2i cocktail (MEK and GSK3-β inhibitor) (Ying et al.,
2008). The work of Hou et al. (2013) represents a landmark
approach in terms of providing a road map for the
generation of iPSCs. Their approach involved the possible
upregulation of endodermal-associated genes followed
by the inhibition of the differentiation processes by the 2i
cocktail (Hou et al., 2013). However, challenges remain
in terms of translating this finding to the development of
human iPSCs due to differences in the response of the 2i
cocktail in mouse and human cells (De Los Angeles and
Daley, 2013). In this regard, development of advanced
methods, such as circular chromosome conformation
capture-sequencing, to characterize the dynamic changes
in chromatin would be useful. This methodology can
complement the studies involving transcription factors
and other epigenetic changes like DNA methylation and
histone modification modulating gene expression. Using
this method, key protein-like mediator and cohesin
components have been identified that are involved in the

reorganization of chromatin and specific subunits that
play a role in differentiation as well as reprogramming.
Rearrangement at the Nanog locus has been shown
to precede transcriptional regulation reprogramming
genes, thereby implying a possible causative, long-range,
interaction-based mechanistic link (Apostolou et al.,
2013; Ferrari et al., 2014). Epigenetic reprogramming of
the unipotent PGCs into a pluripotent state involves a
wave of hypomethylation. Differentiation of such cells
is also associated with changes in the epigenome and is
correlated with cell fate and lineage commitment (Lee et
al., 2014). Detailed analysis of such dynamic and complex
events would require application of current, state-ofthe-art experimental and computational methods. Such
methods, including the use of mathematical models,
should take into account coordinate regulation and
temporal variations at the subcellular, intercellular, and
niche levels. Filling such knowledge gaps would help
in better understanding not only PGCs and EGCs, but
would also improve our understanding of pluripotency
and epigenetic reprogramming of other cell types into the
stem cell lineage (Wu and Tzanakakis, 2013) with obvious
ramifications in cell-based therapies.
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